These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23974363)

  • 1. Chromoplexy: a new paradigm in genome remodeling and evolution.
    Wang K; Wang Y; Collins CC
    Asian J Androl; 2013 Nov; 15(6):711-2. PubMed ID: 23974363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromoplexy: a new category of complex rearrangements in the cancer genome.
    Shen MM
    Cancer Cell; 2013 May; 23(5):567-9. PubMed ID: 23680143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Punctuated evolution of prostate cancer genomes.
    Baca SC; Prandi D; Lawrence MS; Mosquera JM; Romanel A; Drier Y; Park K; Kitabayashi N; MacDonald TY; Ghandi M; Van Allen E; Kryukov GV; Sboner A; Theurillat JP; Soong TD; Nickerson E; Auclair D; Tewari A; Beltran H; Onofrio RC; Boysen G; Guiducci C; Barbieri CE; Cibulskis K; Sivachenko A; Carter SL; Saksena G; Voet D; Ramos AH; Winckler W; Cipicchio M; Ardlie K; Kantoff PW; Berger MF; Gabriel SB; Golub TR; Meyerson M; Lander ES; Elemento O; Getz G; Demichelis F; Rubin MA; Garraway LA
    Cell; 2013 Apr; 153(3):666-77. PubMed ID: 23622249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Words of wisdom: Re: Punctuated evolution of prostate cancer genomes.
    Adler D; Offermann A; Perner S
    Eur Urol; 2014 Mar; 65(3):666-7. PubMed ID: 24484760
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genomic complexity of primary human prostate cancer.
    Berger MF; Lawrence MS; Demichelis F; Drier Y; Cibulskis K; Sivachenko AY; Sboner A; Esgueva R; Pflueger D; Sougnez C; Onofrio R; Carter SL; Park K; Habegger L; Ambrogio L; Fennell T; Parkin M; Saksena G; Voet D; Ramos AH; Pugh TJ; Wilkinson J; Fisher S; Winckler W; Mahan S; Ardlie K; Baldwin J; Simons JW; Kitabayashi N; MacDonald TY; Kantoff PW; Chin L; Gabriel SB; Gerstein MB; Golub TR; Meyerson M; Tewari A; Lander ES; Getz G; Rubin MA; Garraway LA
    Nature; 2011 Feb; 470(7333):214-20. PubMed ID: 21307934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Genomic Characteristics and Origin of Chromothripsis.
    Marcozzi A; Pellestor F; Kloosterman WP
    Methods Mol Biol; 2018; 1769():3-19. PubMed ID: 29564814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct genomic aberrations associated with ERG rearranged prostate cancer.
    Demichelis F; Setlur SR; Beroukhim R; Perner S; Korbel JO; Lafargue CJ; Pflueger D; Pina C; Hofer MD; Sboner A; Svensson MA; Rickman DS; Urban A; Snyder M; Meyerson M; Lee C; Gerstein MB; Kuefer R; Rubin MA
    Genes Chromosomes Cancer; 2009 Apr; 48(4):366-80. PubMed ID: 19156837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer.
    Kovtun IV; Murphy SJ; Johnson SH; Cheville JC; Vasmatzis G
    Oncotarget; 2015 Oct; 6(30):29087-96. PubMed ID: 26337081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Phased Mutations and Complex Rearrangements in Human Prostate Cancer Cell Lines through Linked-Read Whole-Genome Sequencing.
    Pham MT; Gupta A; Gupta H; Vaghasia A; Skaist A; Garrison MA; Coulter JB; Haffner MC; Zheng SL; Xu J; DeStefano Shields C; Isaacs WB; Wheelan SJ; Nelson WG; Yegnasubramanian S
    Mol Cancer Res; 2022 Jul; 20(7):1013-1020. PubMed ID: 35452513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer.
    Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM
    Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Brief: Chromothripsis and cancer.
    Wyatt AW; Collins CC
    J Pathol; 2013 Sep; 231(1):1-3. PubMed ID: 23744564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic factors underlying prostate cancer.
    Luo JH; Yu YP
    Expert Rev Mol Med; 2003 Apr; 5(12):1-26. PubMed ID: 14585168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation mapping reveals novel large genomic rearrangements in prostate cancer.
    Jaratlerdsiri W; Chan EKF; Petersen DC; Yang C; Croucher PI; Bornman MSR; Sheth P; Hayes VM
    Oncotarget; 2017 Apr; 8(14):23588-23602. PubMed ID: 28423598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cells Comprising the Prostate Cancer Microenvironment Lack Recurrent Clonal Somatic Genomic Aberrations.
    Bianchi-Frias D; Basom R; Delrow JJ; Coleman IM; Dakhova O; Qu X; Fang M; Franco OE; Ericson NG; Bielas JH; Hayward SW; True L; Morrissey C; Brown L; Bhowmick NA; Rowley D; Ittmann M; Nelson PS
    Mol Cancer Res; 2016 Apr; 14(4):374-84. PubMed ID: 26753621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer.
    Bermudo R; Abia D; Benitez D; Carrió A; Vilella R; Ortiz AR; Thomson TM; Fernández PL
    Ann N Y Acad Sci; 2010 Oct; 1210():17-24. PubMed ID: 20973795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent advancements in prostate cancer basic research].
    Inoue T; Ogawa O
    Nihon Rinsho; 2016 Jan; 74(1):7-12. PubMed ID: 26793872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of complex genomic rearrangements in cancers using CouGaR.
    Dzamba M; Ramani AK; Buczkowicz P; Jiang Y; Yu M; Hawkins C; Brudno M
    Genome Res; 2017 Jan; 27(1):107-117. PubMed ID: 27986820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer.
    Bismar TA; Yoshimoto M; Vollmer RT; Duan Q; Firszt M; Corcos J; Squire JA
    BJU Int; 2011 Feb; 107(3):477-85. PubMed ID: 20590547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.